STOCK TITAN

[144] Viatris Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Viatris Inc. (VTRS) submitted a Form 144 reporting a proposed sale of 7,032 common shares with an aggregate market value of $72,044.59. The filing lists 1,165,872,127 shares outstanding and an approximate sale date of 09/11/2025 on NASDAQ. The securities were acquired on 03/04/2025 as restricted stock units that vested and are described as a compensatory payment. The broker/contact block lists an address for Viatris Inc. in Canonsburg, PA. The filer reports no sales of the issuer's securities in the past three months and includes the standard representation that the seller does not possess undisclosed material adverse information.

Positive
  • Disclosure compliance: The filer provided required Rule 144 details including acquisition date, nature of acquisition, and planned sale date
  • Compensatory origin disclosed: Securities were acquired via restricted stock unit vesting on 03/04/2025, clearly labeled as a compensatory payment
Negative
  • None.

Insights

TL;DR: Routine Rule 144 notice for vested RSUs; procedural compliance, no disclosed material prior sales.

The filing documents a routine compliance disclosure under Rule 144 for the proposed resale of 7,032 common shares acquired via a restricted stock unit vesting event on 03/04/2025. The filer states the sale will be executed through NASDAQ with an approximate date of 09/11/2025 and reports no issuer-related sales in the prior three months. From a compliance standpoint, the notice provides the required acquisition and payment details and includes the standard attestation regarding material nonpublic information. There are no indications of aggregated selling by related parties in this filing.

TL;DR: Small compensatory RSU sale; immaterial to capitalization but appropriately disclosed.

This Form 144 reports shares resulting from compensatory RSU vesting rather than an open-market purchase, which is common for executive and employee compensation. The size—7,032 shares valued at $72,044.59 against 1,165,872,127 shares outstanding—suggests the transaction is immaterial to Viatris' capital structure. The filing contains required details about acquisition date, nature of acquisition, and intended sale channel, supporting transparency ahead of the proposed sale date.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed by Viatris (VTRS) report?

The filing reports a proposed sale of 7,032 common shares valued at $72,044.59, with an approximate sale date of 09/11/2025 on NASDAQ.

How were the shares acquired according to the filing?

The shares were acquired on 03/04/2025 through a restricted stock unit vest and are described as a compensatory payment.

Does the filing show any sales of Viatris securities in the past three months?

No. The section for securities sold during the past three months states Nothing to Report.

How many Viatris shares are outstanding per the Form 144?

The filing lists 1,165,872,127 shares outstanding.

Who is listed as the broker or contact in the filing?

The broker/name and address block shows VIATRIS INC 1000 MYLAN BLVD CANONSBURG PA 15317 as provided in the notice.
Viatris Inc Ord Shs

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

11.96B
1.15B
0.28%
85.61%
3.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG